There is no denying the impact of CRISPR-Cas9 technology
as a molecular tool for understanding basic biology, but
recent advances push the gene-editing platform from analytic
resource to therapeutic solution. This webinar will present
efforts to address the challenges of genome modification as
therapy, whether by improving fidelity, introducing fail-safes, or
working ex vivo.
Natalia Gomez-Ospina, MD, PhD
Taube Pediatric Neurodegenerative Disease Scholar
Assistant Professor, Dept. of Pediatrics
Divisions of Medical Genetics & Stem Cell and Regenerative Medicine
Developing gene-based therapies for metabolic and neurodegenerative diseases.
Pranam Chatterjee, PhD
Carlos M. Varsavsky Research Fellow
Harvard Medical School | MIT Media Lab
Next generation CRISPR technologies for potential clinical use.
Interested in sponsoring a webinar?
Click here to contact our friendly sales team.